NCT01871311 2019-02-08A Phase I Study of Nilontinib and Cetuximab in Patients With Solid TumorsGeorgetown UniversityPhase 1 Terminated15 enrolled
NCT02205398 2019-01-22Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab TherapyNovartisPhase 1 Terminated13 enrolled
NCT01252628 2018-05-16Phase 1 and 2 Study of PX-866 and CetuximabSeagen Inc.Phase 1/2 Completed178 enrolled